Media

07 Nov 2022

JIXING Announces NMPA Acceptance of New Drug Application Submission for Omecamtiv Mecarbil

Read article

17 Oct 2022

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

Read article

07 Sep 2022

JIXING Announces the Grand Opening of the New Headquarter Office in China

Read article

26 Aug 2022

JIXING Announces the First Patient Enrolled in China Cohort of Phase 3 Clinical Trial of Aficamten

Read article

22 Jul 2022

JIXING Announces First Patients Enrolled in Phase 3 Clinical Study of OC-01 Nasal Spray in China

Read article

01 Jul 2022

JIXING Announces the First Patient Enrollment in Phase 3 Study of Etripamil in China

Read article